Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 33, 724-733, April 1, 1973]
© 1973 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sato, K.
Right arrow Articles by Weinhouse, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sato, K.
Right arrow Articles by Weinhouse, S.

Characterization of Glycogen Synthetases and Phosphorylases in Transplantable Rat Hepatomas1

Kiyomi Sato2, Harold P. Morris and Sidney Weinhouse

The Fels Research Institute and Department of Biochemistry, Temple University School of Medicine, Philadelphia, Pennsylvania, 19140 [K. S. S. W.], and the Department of Biochemistry, Howard University, Washington, D. C. 20001 [H. P. M.]

A study of the chemical and kinetic properties of a series of transplantable, chemically induced rat hepatomas has revealed profound alterations in isozyme patterns of glycogen synthetase and phosphorylase. Highly differentiated, slow-growing hepatomas retain the liver-type isozymes, but with decreased differentiation and increased growth rate these are largely or entirely replaced by nonhepatic isozymes. The phosphorylase of poorly differentiated hepatomas was a third form, shown by isoelectric focusing and by immunochemical criteria to be different from either the liver or muscle isozymes. This form was also present in 21-day fetal liver, together with the adult liver isozyme. All of the hepatomas contained the phosphatases and kinases that interconvert the a and b forms, and preliminary data indicate that the synthetase phosphatase of the poorly differentiated hepatomas also is different from the liver phosphatase.

Total synthetase activity was high in liver and muscle, lower in the well- to highly differentiated hepatomas, and very low in poorly differentiated tumors, except for the Novikoff ascites hepatoma, the only one of the poorly differentiated tumors that stored appreciable glycogen. In all tissues, b form predominated. Total phosphorylase activity was highest in muscle, predominantly in the b form; lower in liver; and still lower in tumors. There was no correlation between the activity of tumor phosphorylase and the degree of differentiation or the storage of glycogen, and most of the liver and hepatoma phosphorylase was in the a form.

1 This work was aided by Grants CA-12227, 10729, and CA-10916 from the National Cancer Institute and Grant BC-74 from the American Cancer Society. A preliminary report of this work was given at the 1972 Annual Meeting of the American Association for Cancer Research, and preliminary data on phosphorylases have been published (29, 31).

2 On leave from the Department of Biochemistry, Tohoku University, Institute of Tuberculosis, Leprosy and Cancer, Sendai, Japan. Present address: Department of Biochemistry, Hirosaki University School of Medicine, Hirosaki, Japan.

Received 11/22/72. Accepted 1/11/73.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1973 by the American Association for Cancer Research.